Australia markets closed

T2 Biosystems, Inc. (TTOO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.8400+0.1000 (+3.65%)
At close: 04:00PM EDT
2.9000 +0.06 (+2.11%)
After hours: 07:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
23,802
7,193
22,305
28,058
18,130
Cost of revenue
22,733
15,363
21,010
20,703
21,280
Gross profit
1,069
-8,170
1,295
7,355
-3,150
Operating expenses
Research development
26,409
14,153
25,715
21,801
16,112
Selling general and administrative
30,615
24,830
30,625
28,527
22,094
Total operating expenses
57,024
38,983
56,340
50,328
38,206
Operating income or loss
-55,955
-47,153
-55,045
-42,973
-41,356
Interest expense
5,500
5,343
6,084
7,596
5,518
Total other income/expenses net
-2,693
2,419
-874
1,216
62
Income before tax
-64,048
-50,077
-62,003
-49,241
-46,798
Income from continuing operations
-64,048
-50,077
-62,003
-49,241
-46,798
Net income
-64,048
-50,077
-62,003
-49,241
-46,798
Net income available to common shareholders
-64,378
-50,077
-62,333
-49,241
-46,798
Basic EPS
-35.62
-
-1.22k
-1.55k
-1.95k
Diluted EPS
-35.62
-
-1.22k
-1.55k
-1.95k
Basic average shares
1,386
-
51.003
31.772
24.266
Diluted average shares
1,386
-
51.003
31.772
24.266